Literature DB >> 16039272

Modulation of I(Kr) inactivation by mutation N588K in KCNH2: a link to arrhythmogenesis in short QT syndrome.

J M Cordeiro1, R Brugada, Y S Wu, K Hong, R Dumaine.   

Abstract

OBJECTIVE: Short QT syndrome (SQTS) is characterized by ventricular arrhythmias and sudden death. One form of SQTS is caused by mutation N588K in human ether-a-go-go-related gene (HERG). In this study we sought to determine the potential role of N588K in arrhythmias.
METHODS: We measured the characteristics of HERG current generated by wild-type (WT) KCNH2 and the N588K mutant channel expressed in mammalian TSA201 cells.
RESULTS: Whole-cell patch-clamp recordings of WT HERG currents showed the usual rapid onset of inactivation (rectification) at potentials more positive than +10 mV. In contrast, N588K currents rectified at potentials over +80 mV. Over the physiological range of potentials, N588K currents do not inactivate. During an action potential clamp, WT currents displayed a "hump" like waveform with slow activation kinetics and a rapid increase during phase 3 repolarization. In contrast, N588K currents were proportional to the amplitude of the action potential and displayed a dome-like configuration and a much larger current during the initial phases in the ventricle. Purkinje cell action potentials display a more negative phase 2 repolarization than the ventricle and elicited much smaller WT and N588K currents of similar amplitudes.
CONCLUSIONS: Physiologically the N588K mutation abolishes rectification of HERG currents and specifically increases I(Kr) in the ventricle with minimal effects on the Purkinje fiber action potential duration. Such preferential prolongation may explain the separation of the T and U waves observed in the ECG of SQTS patients and lead to re-excitation of the ventricle endocardium.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16039272     DOI: 10.1016/j.cardiores.2005.02.018

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  46 in total

1.  The Link between Inactivation and High-Affinity Block of hERG1 Channels.

Authors:  Wei Wu; Alison Gardner; Michael C Sanguinetti
Journal:  Mol Pharmacol       Date:  2015-04-08       Impact factor: 4.436

2.  Disopyramide: although potentially life-threatening in the setting of long QT, could it be life-saving in short QT syndrome?

Authors:  R Dumaine; C Antzelevitch
Journal:  J Mol Cell Cardiol       Date:  2006-07-25       Impact factor: 5.000

Review 3.  Short QT syndrome review.

Authors:  Nathan E Van Houzen; Alawi A Alsheikh-Ali; Ann C Garlitski; Munther K Homoud; Jonathan Weinstock; Mark S Link; N A Mark Estes
Journal:  J Interv Card Electrophysiol       Date:  2008-02-26       Impact factor: 1.900

4.  Pharmacology of the short QT syndrome N588K-hERG K+ channel mutation: differential impact on selected class I and class III antiarrhythmic drugs.

Authors:  M J McPate; R S Duncan; J C Hancox; H J Witchel
Journal:  Br J Pharmacol       Date:  2008-08-25       Impact factor: 8.739

5.  The G604S-hERG mutation alters the biophysical properties and exerts a dominant-negative effect on expression of hERG channels in HEK293 cells.

Authors:  Jianhua Huo; Yanmin Zhang; Na Huang; Ping Liu; Chen Huang; Xueyan Guo; Wenhui Jiang; Nan Zhou; Andrew Grace; Christopher L H Huang; Aiqun Ma
Journal:  Pflugers Arch       Date:  2008-04-03       Impact factor: 3.657

Review 6.  Short QT syndrome.

Authors:  Ramon Brugada; Kui Hong; Jonathan M Cordeiro; Robert Dumaine
Journal:  CMAJ       Date:  2005-11-22       Impact factor: 8.262

Review 7.  [Standard-ECG].

Authors:  Bernd-Dieter Gonska
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-09

8.  Congenital short QT syndrome.

Authors:  Lia Crotti; Erika Taravelli; Giulia Girardengo; Peter J Schwartz
Journal:  Indian Pacing Electrophysiol J       Date:  2010-02-01

9.  Action potential clamp and chloroquine sensitivity of mutant Kir2.1 channels responsible for variant 3 short QT syndrome.

Authors:  Aziza El Harchi; Mark J McPate; Yi hong Zhang; Henggui Zhang; Jules C Hancox
Journal:  J Mol Cell Cardiol       Date:  2009-03-10       Impact factor: 5.000

10.  hERG1a/1b heteromeric currents exhibit amplified attenuation of inactivation in variant 1 short QT syndrome.

Authors:  M J McPate; H Zhang; J M Cordeiro; C E Dempsey; H J Witchel; J C Hancox
Journal:  Biochem Biophys Res Commun       Date:  2009-06-06       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.